GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 22 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,000 | -17.6% | 9,116 | 0.0% | 0.00% | – |
| Q4 2021 | $17,000 | -32.0% | 9,116 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | -10.7% | 9,116 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -9.7% | 9,116 | 0.0% | 0.00% | – |
| Q1 2021 | $31,000 | +29.2% | 9,116 | +19.7% | 0.00% | – |
| Q4 2020 | $24,000 | +14.3% | 7,614 | +29.6% | 0.00% | – |
| Q3 2020 | $21,000 | -25.0% | 5,877 | 0.0% | 0.00% | – |
| Q2 2020 | $28,000 | -15.2% | 5,877 | +23.3% | 0.00% | – |
| Q4 2018 | $33,000 | – | 4,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|